Title: Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy.
Journal: Medical oncology (Northwood, London, England) 20121201
Title: Pharmacokinetics and tolerability of anagrelide hydrochloride in young (18 - 50 years) and elderly (≥ 65 years) patients with essential thrombocythemia.
Journal: International journal of clinical pharmacology and therapeutics 20121101
Title: Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine.
Journal: International journal of cardiology 20121004
Title: Front-line therapy in polycythemia vera and essential thrombocythemia.
Journal: Blood reviews 20120901
Title: Platelet-lowering therapy with anagrelide as an adjuvant therapy for treatment of primary pulmonary neoplasm-associated extreme thrombocytosis.
Journal: Japanese journal of clinical oncology 20120801
Title: Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists.
Journal: Hematology (Amsterdam, Netherlands) 20120701
Title: How to manage essential thrombocythemia.
Journal: Leukemia 20120501
Title: Ruxolitinib for the treatment of myelofibrosis: its clinical potential.
Journal: Therapeutics and clinical risk management 20120101
Title: Sequential occurrence of thrombotic thrombocytopenic purpura, essential thrombocythemia, and idiopathic thrombocytopenic purpura in a 42-year-old African-American woman: a case report and review of the literature.
Journal: Journal of medical case reports 20120101
Title: Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.
Journal: Leukemia research 20111201
Title: Anagrelide and cardiovascular events. Much ado about nothing?
Journal: Leukemia research 20111201
Title: cGMP Signaling, Phosphodiesterases and Major Depressive Disorder.
Journal: Current neuropharmacology 20111201
Title: Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.
Journal: Clinical epigenetics 20110801
Title: Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis.
Journal: Korean circulation journal 20110701
Title: Stress cardiomyopathy complicated by left ventricular thrombi and cerebral infarctions in a patient with essential thrombocythemia.
Journal: Journal of cardiovascular ultrasound 20110601
Title: [Differential diagnosis of clinical relevance].
Journal: Therapeutische Umschau. Revue therapeutique 20110301
Title: [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Journal: Vnitrni lekarstvi 20110201
Title: Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.
Journal: Leukemia 20110101
Title: Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.
Journal: Cancer management and research 20110101
Title: Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.
Journal: Orphanet journal of rare diseases 20110101
Title: Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.
Journal: Thrombosis 20110101
Title: Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms.
Journal: Thrombosis 20110101
Title: Management of essential thrombocythemia.
Journal: Hematology. American Society of Hematology. Education Program 20110101
Title: Emerging treatments for essential thrombocythemia.
Journal: Journal of blood medicine 20110101
Title: Compensatory thrombopoietin production from the liver and bone marrow stimulates thrombopoiesis of living rat megakaryocytes in chronic renal failure.
Journal: Nephron extra 20110101
Title: [Two clinical cases of essential thrombocythemia complicated by thrombosis in parturients].
Journal: Likars'ka sprava 20110101
Title: Anagrelide represses GATA-1 and FOG-1 expression without interfering with thrombopoietin receptor signal transduction.
Journal: Journal of thrombosis and haemostasis : JTH 20101001
Title: Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status.
Journal: Leukemia & lymphoma 20100901
Title: Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report.
Journal: The Korean journal of hematology 20100601
Title: Anagrelide for the treatment of thrombocythaemia in daily clinical practice: a post-marketing observational survey on efficacy and safety performed in Germany.
Journal: Onkologie 20100101
Title: JAK2 mutation and thrombosis in the myeloproliferative neoplasms.
Journal: Current hematologic malignancy reports 20100101
Title: Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature.
Journal: Thrombosis journal 20100101
Title: [Diagnosis and therapy for patients with essential thrombocythemia. Guidelines of Croatian Cooperative Group for hematologic disorders--KROHEM].
Journal: Lijecnicki vjesnik 20100101
Title: JAK2 Negative Polycythemia Vera.
Journal: Journal of laboratory physicians 20100101
Title: Chronic myeloproliferative neoplasms: a collaborative approach.
Journal: Mediterranean journal of hematology and infectious diseases 20100101
Title: Essential thrombocythemia: aeromedical considerations.
Journal: Aviation, space, and environmental medicine 20091101
Title: [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
Journal: Vnitrni lekarstvi 20091101
Title: Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis.
Journal: Clinical therapeutics 20091101
Title: Essential thrombocythemia: past and present.
Journal: Internal and emergency medicine 20091001
Title: Myelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm.
Journal: Journal of hematopathology 20090901
Title: Atypical Takotsubo syndrome during anagrelide therapy.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.) 20090701
Title: Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090620
Title: [Retrospective analysis of the efficacy and tolerability of anagrelide in patients with essential thrombocytemia: Spanish registry of essential thrombocytemia].
Journal: Medicina clinica 20090620
Title: Role of platelet counts in the management of essential thrombocythemia: experience with anagrelide.
Journal: Expert review of hematology 20090601
Title: Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists.
Journal: Hematology (Amsterdam, Netherlands) 20090201
Title: Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden.
Journal: Hematology (Amsterdam, Netherlands) 20090201
Title: Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
Journal: Clinical therapeutics 20090201
Title: Long-term management of thrombocytosis in essential thrombocythaemia.
Journal: Annals of hematology 20090101
Title: Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
Journal: Leukemia research 20090101
Title: Anagrelide: 20 years later.
Journal: Expert review of anticancer therapy 20090101
Title: Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.
Journal: Acta haematologica 20090101
Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.
Journal: PloS one 20090101
Title: Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review.
Journal: Acta haematologica 20090101
Title: Pathogenesis and management of essential thrombocythemia.
Journal: Hematology. American Society of Hematology. Education Program 20090101
Title: The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy.
Journal: Leukemia & lymphoma 20081101
Title: Successful rechallenge with anagrelide in a patient with anagrelide-associated cardiomyopathy.
Journal: Annals of hematology 20080801
Title: Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.
Journal: Leukemia 20080801
Title: Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
Journal: Blood 20080101
Title: Essential thrombocytemia and acute coronary syndrome: clinical profile and association with other thromboembolic events.
Journal: Acute cardiac care 20080101
Title: Aortic valve replacement in a young patient with essential thrombocytosis.
Journal: Journal of cardiothoracic surgery 20080101
Title: TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
Journal: International journal of medical sciences 20080101
Title: [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
Journal: Vnitrni lekarstvi 20080101
Title: [Anagrelide for treatment of patients with essential thrombocythaemia].
Journal: Lijecnicki vjesnik 20080101
Title: Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy.
Journal: Acta haematologica 20080101
Title: Myelofibrosis: biology and treatment options.
Journal: European journal of haematology. Supplementum 20071001
Title: Essential thrombocythaemia treatment options: addressing patient-specific needs.
Journal: European journal of haematology. Supplementum 20071001
Title: Options in the management of essential thrombocythaemia.
Journal: European journal of haematology. Supplementum 20071001
Title: Practical approach to treating essential thrombocythaemia: case studies.
Journal: European journal of haematology. Supplementum 20071001
Title: Essential versus reactive thrombocythemia in children: retrospective analyses of 12 cases.
Journal: Pediatric blood & cancer 20070701
Title: Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
Journal: The Israel Medical Association journal : IMAJ 20070701
Title: Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
Journal: Seminars in thrombosis and hemostasis 20070601
Title: [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
Journal: Vnitrni lekarstvi 20070601
Title: Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
Journal: Biologics : targets & therapy 20070601
Title: Acute coronary syndromes and Anagrelide.
Journal: International journal of cardiology 20070412
Title: Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
Journal: Leukemia 20070301
Title: Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis.
Journal: American journal of clinical pathology 20070301
Title: [Appearance of leg ulcers associated with intake of anagrelide].
Journal: Deutsche medizinische Wochenschrift (1946) 20070216
Title: Essential thrombocythemia.
Journal: Orphanet journal of rare diseases 20070101
Title: A novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera.
Journal: International journal of immunopathology and pharmacology 20070101
Title: Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Journal: Medical oncology (Northwood, London, England) 20070101
Title: Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.
Journal: BMC pharmacology 20070101
Title: Expertise-based management in essential thrombocythemia and polycythemia vera.
Journal: Cancer journal (Sudbury, Mass.) 20070101
Title: Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia.
Journal: Acta haematologica 20070101
Title: Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Journal: Platelets 20061201
Title: Hematoma of a congenitally bicuspid aortic valve in a patient with polycythemia vera and the antiphospholipid antibody syndrome.
Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20061201
Title: Long-term use of anagrelide in the treatment of children with essential thrombocythemia.
Journal: European journal of haematology 20061001
Title: Advances in the therapy of chronic idiopathic myelofibrosis.
Journal: The oncologist 20060901
Title: [Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase].
Journal: Vnitrni lekarstvi 20060901
Title: [Primary thrombocythemia: diagnosis and therapy].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20060815
Title: Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
Journal: American journal of hematology 20060801
Title: Current management of the myeloproliferative disorders: a case-based review.
Journal: Archives of pathology & laboratory medicine 20060801
Title: Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.
Journal: Blood 20060601
Title: Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineage.
Journal: Leukemia 20060601
Title: Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
Journal: Prescrire international 20060601
Title: Effects of anagrelide on megakaryopoiesis and platelet production.
Journal: Seminars in thrombosis and hemostasis 20060601
Title: Anagrelide: what was new in 2004 and 2005?
Journal: Seminars in thrombosis and hemostasis 20060601
Title: Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders.
Journal: Seminars in thrombosis and hemostasis 20060601
Title: Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Journal: Seminars in thrombosis and hemostasis 20060601
Title: Update on diagnosis and management of essential thrombocythemia.
Journal: Seminars in thrombosis and hemostasis 20060601
Title: Coronary artery intervention after cytostatics treatment in unstable angina patient with essential thrombocythemia. A case report and literature review.
Journal: The Korean journal of internal medicine 20060601
Title: Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
Journal: Cancer genetics and cytogenetics 20060501
Title: JAK2 V617F: a single mutation in the myeloproliferative group of disorders.
Journal: The Ulster medical journal 20060501
Title: [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
Journal: Vnitrni lekarstvi 20060501
Title: Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia.
Journal: Seminars in thrombosis and hemostasis 20060401
Title: Anagrelide treatment in myeloproliferative disorders.
Journal: Seminars in thrombosis and hemostasis 20060401
Title: Management of essential thrombocythemia: implications of the medical research council primary thrombocythemia 1 trial.
Journal: Seminars in thrombosis and hemostasis 20060401
Title: Essential thrombocythemia: scientific advances and current practice.
Journal: Current opinion in hematology 20060301
Title: 'Double hit' from streptococcal pneumonia and hypersensitivity pneumonitis associated with anagrelide.
Journal: Clinical and laboratory haematology 20060201
Title: Bilateral adrenal hemorrhage associated with essential thrombocytosis.
Journal: American journal of hematology 20060201
Title: Anagrelide: a review of its use in the management of essential thrombocythaemia.
Journal: Drugs 20060101
Title: A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
Journal: Experimental hematology 20060101
Title: [The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].
Journal: Duodecim; laaketieteellinen aikakauskirja 20060101
Title: Polycythaemia vera and essential thrombocythaemia: current treatment strategies.
Journal: Drugs 20060101
Title: [Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features].
Journal: Medicina 20060101
Title: Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
Journal: Lancet (London, England) 20051203
Title: [Treatment of essential thrombocythemia].
Journal: La Revue de medecine interne 20051201
Title: Successful outcome with anagrelide in pregnancy.
Journal: Annals of hematology 20051001
Title: Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.
Journal: British journal of pharmacology 20051001
Title: Anagrelide does not exert a myelodysplastic effect on megakaryopoiesis: a comparative immunohistochemical and morphometric study with hydroxyurea.
Journal: Histology and histopathology 20051001
Title: Essential thrombocythemia.
Journal: Seminars in hematology 20051001
Title: Anagrelide for control of thrombocytosis due to myeloproliferative disorders.
Journal: Future oncology (London, England) 20051001
Title: Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
Journal: Blood reviews 20050901
Title: Treatment of symptomatic patients with essential thrombocythemia: effectiveness of anagrelide.
Journal: American journal of hematology 20050901
Title: High-output heart failure associated with anagrelide therapy for essential thrombocytosis.
Journal: Annals of internal medicine 20050816
Title: High-performance liquid chromatography-mass spectrometry method for determination of anagrelide in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805
Title: Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement.
Journal: Stroke 20050801
Title: Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Journal: The New England journal of medicine 20050707
Title: When and how to treat essential thrombocythemia.
Journal: The New England journal of medicine 20050707
Title: Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
Journal: European journal of haematology 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Renal tubular injury associated with anagrelide use.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050501
Title: Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders.
Journal: Leukemia research 20050501
Title: A critical review of anagrelide therapy in essential thrombocythemia and related disorders.
Journal: Leukemia & lymphoma 20050501
Title: Primary and secondary thrombocytosis in childhood.
Journal: British journal of haematology 20050401
Title: Current treatment of myelofibrosis.
Journal: Clinical advances in hematology & oncology : H&O 20050401
Title: PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
Journal: American journal of hematology 20050201
Title: Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
Journal: Leukemia 20050101
Title: Myeloproliferative disorders.
Journal: Clinical medicine (London, England) 20050101
Title: [Clinical application of anagrelide as a selective inhibitor of megakaryocyte system].
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960) 20050101
Title: [Anagrelide in the treatment of thrombocythemia essential (ET)].
Journal: Polskie Archiwum Medycyny Wewnetrznej 20041201
Title: Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Journal: Cancer 20041115
Title: Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia.
Journal: Annals of hematology 20041101
Title: [Unclear liver fibrosis in a 42-year-old patient with polycythemia vera].
Journal: Der Internist 20041101
Title: A long-term study of young patients with essential thrombocythemia treated with anagrelide.
Journal: Haematologica 20041101
Title: Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia.
Journal: Haematologica 20041101
Title: Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
Journal: Clinical and laboratory haematology 20041001
Title: Anagrelide-induced visual hallucinations in a patient with essential thrombocythemia.
Journal: European journal of haematology 20040901
Title: Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essential thrombocythemia.
Journal: British journal of haematology 20040901
Title: Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemia.
Journal: Expert opinion on pharmacotherapy 20040801
Title: Anagrelide: an update on its mechanisms of action and therapeutic potential.
Journal: Expert review of anticancer therapy 20040801
Title: Thrombocytosis.
Journal: The New England journal of medicine 20040610
Title: Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Journal: Haematologica 20040501
Title: Essential thrombocythaemia in children: is a treatment needed?
Journal: Expert opinion on pharmacotherapy 20040501
Title: The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?
Journal: Seminars in hematology 20040401
Title: Treatment paradigms in the management of myeloproliferative disorders.
Journal: Seminars in hematology 20040401
Title: Thrombocytosis.
Journal: The New England journal of medicine 20040318
Title: Thrombocytosis in an infant with high thrombopoietin concentrations.
Journal: Journal of pediatric hematology/oncology 20040201
Title: Thalidomide for the treatment of idiopathic myelofibrosis.
Journal: European journal of haematology 20040101
Title: Essential thrombocythemia-related acute ST-segment elevation myocardial infarction. A case report and literature review.
Journal: Angiology 20040101
Title: Management of the myeloproliferative disorders : distinguishing data from dogma.
Journal: The hematology journal : the official journal of the European Haematology Association 20040101
Title: [Retrospective analysis of the clinical course of 12 children given the diagnosis essential thrombocythemia].
Journal: Klinische Padiatrie 20040101
Title: [Diagnostic and therapeutic management of essential thrombocythemia in children].
Journal: Medycyna wieku rozwojowego 20040101
Title: [Recurring ischemic cerebral infarction caused by primary thrombocytosis in infancy].
Journal: Revista de neurologia 20031201
Title: Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
Journal: Haematologica 20031001
Title: Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
Journal: Cancer chemotherapy and pharmacology 20030901
Title: Severe hypersensitivity pneumonitis associated with anagrelide.
Journal: The Annals of pharmacotherapy 20030901
Title: Pharmacotherapy of essential thrombocythaemia: economic considerations.
Journal: Expert opinion on pharmacotherapy 20030901
Title: Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Journal: American journal of hematology 20030901
Title: [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
Journal: Nederlands tijdschrift voor geneeskunde 20030802
Title: Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis.
Journal: Blood 20030501
Title: Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
Journal: Current hematology reports 20030501
Title: Portal vein thrombosis after laparoscopy-assisted splenectomy and cholecystectomy.
Journal: Journal of pediatric surgery 20030401
Title: New approaches to the treatment of thrombocytosis.
Journal: Clinical advances in hematology & oncology : H&O 20030201
Title: Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Journal: Cancer chemotherapy and pharmacology 20030101
Title: Indications for lowering platelet numbers in essential thrombocythemia.
Journal: Seminars in hematology 20030101
Title: Modern treatment strategies in polycythemia vera.
Journal: Seminars in hematology 20030101
Title: Treatment of essential thrombocythemia in childhood.
Journal: Pediatric hematology and oncology 20030101
Title: Essential thrombocytosis: diagnostic and treatment dilemmas.
Journal: The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20030101
Title: Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations.
Journal: Thrombosis research 20030101
Title: Essential thrombocythemia (ET): moving from palliation to cure.
Journal: Hematology (Amsterdam, Netherlands) 20021201
Title: [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
Journal: Der Pathologe 20021101
Title: Comparison of the pharmacological mechanisms involved in the platelet lowering actions of anagrelide and hydroxyurea: a review.
Journal: Platelets 20021101
Title: Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Journal: Transplantation 20021027
Title: What is the standard treatment in essential thrombocythemia.
Journal: International journal of hematology 20020801
Title: Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?
Journal: Experimental hematology 20020701
Title: Therapeutic options for essential thrombocythemia and polycythemia vera.
Journal: Seminars in oncology 20020601
Title: Other secondary sequelae of treatments for myeloproliferative disorders.
Journal: Seminars in oncology 20020601
Title: Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Journal: Seminars in oncology 20020601
Title: Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.
Journal: American journal of hematology 20020601
Title: Essential thrombocythemia: diagnosis and treatment, with special emphasis on the use of anagrelide.
Journal: Hematology (Amsterdam, Netherlands) 20020601
Title: Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia.
Journal: Blood 20020301
Title: The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
Journal: Blood 20020215
Title: Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
Journal: British journal of haematology 20020101
Title: Anagrelide-induced erectile dysfunction.
Journal: The Annals of pharmacotherapy 20020101
Title: [Treatment of essential thrombocythemia with anagrelide: a ten-year experience].
Journal: Medicina 20020101
Title: [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Journal: Ugeskrift for laeger 20011203
Title: Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation.
Journal: Experimental hematology 20011201
Title: Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
Journal: Chest 20010901
Title: Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
Journal: Oncology (Williston Park, N.Y.) 20010801
Title: [How should patients with essential thrombocythemia be treated?].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20010601
Title: [Anagrelide in primary thrombocythemia].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010510
Title: Hydroxyurea and periodicity in myeloproliferative disease.
Journal: European journal of haematology 20010501
Title: [The chronic Philadelphia chromosome-negative myeloproliferative syndrome II. Clinical findings, diagnostics and treatment].
Journal: Ugeskrift for laeger 20010430
Title: Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000.
Journal: Pathologie-biologie 20010301
Title: Management of patients with essential thrombocythemia: current concepts and perspectives.
Journal: Pathologie-biologie 20010301
Title: Current treatment practice for essential thrombocythaemia in adults.
Journal: Expert opinion on pharmacotherapy 20010301
Title: A single institutional experience with 43 pregnancies in essential thrombocythemia.
Journal: European journal of haematology 20010301
Title: Long-term use of anagrelide in young patients with essential thrombocythemia.
Journal: Blood 20010215
Title: Current management in polycythemia vera.
Journal: Seminars in hematology 20010101
Title: Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains.
Journal: Journal of medicinal chemistry 19920710
Title: 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Journal: Journal of medicinal chemistry 19920221
Title: Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.
Journal: Journal of medicinal chemistry 19870201
